Tag:#Cannabis Capital Markets

‘Collaborative Vertical Integration Has To Be The Way Forward For the European Cannabis Industry’

BACK in 2019 at a US industry conference while discussing cannabis business models a top executive from JP Morgan said ‘Gap do not...

European Cannabis Stocks Review: ‘End’ Of US Cannabis Bear Market Rallies European Stocks 

FOLLOWING last week’s rally there has seen something of a lull with little movement for European cannabis stocks. Last week’s bounce-back saw a number of...

European Cannabis Round-Up Featuring Ukraine, Portugal, Netherlands, Czechia And The Italian ‘Valley Of CBD’

UKRAINE is poised permit the use of medical cannabis opening up the potential treatment to over two million people. The country’s multimedia news platform ukrinform...

Polish Cannabis Blockchain Start-Up Receives €400,000 Investment To Deliver Seed-To-Sale Supply Chain Security

TRUSTT has secured €400,000 in pre-seed funding to finance its ambitious blockchain tracing platform, which it believes will allow it to become a leading...

Danish Biotech Firm Secures €2m Funding To Support Its Pharma-Focused Medical Cannabis Vision

TETRA Pharm has successfully completed its first external funding round raising €2m in capital to help it launch clinical trials and expand its operations...

Investors Respond Positively To Senior Appointment At Under-Fire UK CBD Firm

CHILL Brands Group saw its stock prices jump as much as 25% after announcing the appointment of Michael Sandore as its new head of...

Will 2022 Be The Year When A Maturing European Cannabis Industry Becomes Mainstream?

FUELLED by last year’s significant progress the European cannabis industry is looking forward to further positive developments in 2022. While there may have been a...

2022 Will See The Race To The Bottom Replaced By A Healthy Focus On Profitable Business Models

Stenocare CEO Thomas Skovlund Schnegelsberg reflects on 2021 and looks ahead to the challenges and opportunities that lie ahead in 2022 BC: What are the main opportunities...

Latest news

Tilray’s Medical Cannabis Product Now Available And Reimbursed Under Ireland’s Medical Cannabis Access Program

PRESS RELEASE TILRAY Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and...
- Advertisement -spot_imgspot_img

Grow Group, Kanabo, MGC Pharma & Celadon Pharma All Report Growing Revenues, But Continue To Post Losses

AMID the economic chaos that dominated the headlines over the past week, nearly half-a-dozen UK-based or UK-listed cannabis companies...

MGC Pharma Announces Appointment Of UK Advisor And New COO/Deputy CEO

MGC Pharmaceuticals Ltd ('MGC Pharma' or 'the Company') a European based bio-pharma company specialising in the production and development...

Must read